The regulatory role of dexmedetomidine in NLRP3 inflammasome-related organ protection.

Abstract

Organ protection is paramount during the perioperative period. Dexmedetomidine, a commonly used anesthetic, has gained attention for its potential anti-inflammatory and organ-protective properties. The NLRP3 inflammasome, a key inflammatory signaling molecule, contributes to organ dysfunction. This review examines recent research investigating dexmedetomidine's ability to protect organs by inhibiting NLRP3 inflammasome activation. A deeper understanding of these mechanisms could lead to novel therapeutic strategies for improving patient outcomes.